Nuo Therapeutics, Inc. (AURX)

Gross Profit Growth

124.76%

TTM · Period ending:

AURX logo

AURX Gross Profit Growth

Year-over-year change vs the same period a year earlier

Latest reported124.76%
AURX TTM Gross Profit YoY % (-65.04% → 124.76%)
High-resolution chart · PNG

AURX gross profit growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Nuo Therapeutics, Inc. Gross Profit Growth — Trailing twelve months (TTM)
Period endingGross Profit Growth
124.7627%
117.7911%
108.782%
102.0902%
81.4226%
101.6613%
120.2028%
134.3714%
238.6485%
332.5187%
426.214%
1,176.5782%
17,902.2861%
100%
-100%
-100%
-66.7395%
-97.4518%
-97.3863%
139.6856%
3,649.184%
784.6606%
426.3813%
185.5072%
106.756%
-29.848%
-162.5019%
-134.829%
-121.9992%
-105.7892%
-83.2957%
-60.2144%
-32.2334%
-17.5803%
257.5362%
73.9278%
47.2958%
5.8333%
-68.2132%
-54.107%
-52.9196%
-55.3718%
-53.1068%
-53.7017%
-50.9238%
-7.4077%
47.1089%
161.2066%
167.6773%
123.9411%
131.9028%
94.9582%
143.2524%
121.0776%
21.2656%
-7.0237%
-24.775%
-18.9094%
7.8983%
15.6457%
18.7241%
15.6772%
36.297%
51.1094%
38.1853%
38.3877%
17.0767%
2.7637%
19.4061%
25.7768%
47.4599%
54.4779%
89.7459%
64.1525%
45.9552%
42.7892%
2.2157%
19.4077%
32.0479%
35.5517%
19.3023%
3.5808%
-2.9291%
39.9265%
225.8183%
512.2273%
276.8438%
21.2305%
-48.0268%
-79.176%
-65.0407%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.